EUVIMEDEUVIMED entdecken
Crossref

Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor-Positive Bronchial Neuroendocrine Tumors

MD, Thomas A Hope,, PhD Lauren Haydu,, MD Andrew Hendifar,, MD Amr Mohamed,, MD Heloisa Soares,, MD Ardaman Shergill,, MD George Fisher,, MD Peter J O'Dwyer,, MD, MPH Jeffrey Meyerhardt,, MD Eileen O'Reilly, und 1 weitere

Endocrine Abstracts · 04.03.2026

DOI: 10.1530/endoabs.116.t9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von MD und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

MD, Hope,, T. A., Haydu,, P. L., Hendifar,, M. A., Mohamed,, M. A., Soares,, M. H., Shergill,, M. A., Fisher,, M. G., O'Dwyer,, M. P. J., MD, Meyerhardt,, M. J., O'Reilly,, M. E., & Padda,, M. S. K. (2026). Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor-Positive Bronchial Neuroendocrine Tumors. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.t9

Vancouver

MD, Hope, TA, Haydu, PL, Hendifar, MA, Mohamed, MA, Soares, MH, et al. Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor-Positive Bronchial Neuroendocrine Tumors. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.t9

BibTeX
@article{MD2026,
  author = {MD and Hope,, Thomas A and Haydu,, PhD Lauren and Hendifar,, MD Andrew and Mohamed,, MD Amr and Soares,, MD Heloisa and Shergill,, MD Ardaman and Fisher,, MD George and O'Dwyer,, MD Peter J and MD and Meyerhardt,, MPH Jeffrey and O'Reilly,, MD Eileen and Padda,, MD Sukhmani K},
  title = {Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor-Positive Bronchial Neuroendocrine Tumors},
  journal = {Endocrine Abstracts},
  year = {2026},
  doi = {10.1530/endoabs.116.t9}
}
Kostenlos starten →